Company news

Share this article:
Pfizer has entered a multi-year agreement with information solutions firm Ingenuity Systems calling for deployment of its proprietary Ingenuity Pathways Analysis (IPA) to be used to explore and share life science and healthcare information. In addition, Pfizer will integrate IPA and content from the Ingenuity knowledge base with other informatics solutions used throughout the Pfizer organization.
Three former Sudler & Hennessey med ed companies have merged into one independent unit, dubbed IME, LLC, under the leadership of managing director Lisa Emusov. IME, LLC, consists of North Wales, PA-based Acumentis; Berkeley Heights, NJ firm Emeritus Educational Sciences; and New York City-based Imprint Science. The three shops were spun off from Sudler & Hennessey in 2004, in response to ACCME's requirement that medical education and communications companies maintain strict separation from parent companies that handle promotion or accept advertising from pharma companies. 
The IronWorks and The StoneWorks, two professional advertising units of The CementBloc group, moved to new offices in New Yorks' Flatiron neighborhood, not far from sister agencies The CementWorks and The CementBond.
Life sciences closed-loop marketing provider, Proscape Technologies announced the opening of offices in Chicago, Toronto, Paris and Amsterdam. Proscape's new locations extend the firm's reach, following office openings in London and Tokyo.
Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Business Briefs

Email Newsletters


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.